Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

24432 ARTÍCULOS , VIENDO DEL 19831 AL 19845

Unfolded p53 in the pathogenesis of Alzheimer's disease: is HIPK2 the link?

Stanga S, Lanni C, Govoni S, Uberti D, D'Orazi G, Racchi M.

Aging (Albany NY). 2010 Sep;2(9):545-54. doi: 10.18632/aging.100205.

JNK: a stress-activated protein kinase therapeutic strategies and involvement in Alzheimer's and various neurodegenerative abnormalities

Mehan S, Meena H, Sharma D, Sankhla R.

J Mol Neurosci. 2011 Mar;43(3):376-90. doi: 10.1007/s12031-010-9454-6. Epub 2010 Sep 28.

Characterizing the regional structural difference of the brain between tau transgenic (rTg4510) and wild-type mice using MRI

Xie Z, Yang D, Stephenson D, Morton D, Hicks C, Brown T, Bocan T.

Med Image Comput Comput Assist Interv. 2010;13(Pt 1):308-15. doi: 10.1007/978-3-642-15705-9_38.

Network excitability dysfunction in Alzheimer's disease: insights from in vitro and in vivo models

Santos SF, Pierrot N, Octave JN.

Rev Neurosci. 2010;21(3):153-71. doi: 10.1515/revneuro.2010.21.3.153.

Changes in CSF acetyl- and butyrylcholinesterase activity after long-term treatment with AChE inhibitors in Alzheimer's disease

Parnetti L, Chiasserini D, Andreasson U, Ohlson M, Hüls C, Zetterberg H, Minthon L, Wallin AK, Andreasen N, Talesa VN, Blennow K.

Acta Neurol Scand. 2011 Aug;124(2):122-9. doi: 10.1111/j.1600-0404.2010.01435.x. Epub 2010 Sep 29.

Physical exercise alleviates debilities of normal aging and Alzheimer's disease

Archer T.

Acta Neurol Scand. 2011 Apr;123(4):221-38. doi: 10.1111/j.1600-0404.2010.01412.x. Epub 2010 Sep 29.

Diabetes-associated SorCS1 regulates Alzheimer's amyloid-beta metabolism: evidence for involvement of SorL1 and the retromer complex

Lane RF, Raines SM, Steele JW, Ehrlich ME, Lah JA, Small SA, Tanzi RE, Attie AD, Gandy S.

J Neurosci. 2010 Sep 29;30(39):13110-5. doi: 10.1523/JNEUROSCI.3872-10.2010.

Transport of drugs across the blood-brain barrier in Alzheimer's disease

Nicolazzo JA, Mehta DC.

Ther Deliv. 2010 Oct;1(4):595-611. doi: 10.4155/tde.10.41.

Finding the right target for treating Alzheimer disease

Mandell BF.

Cleve Clin J Med. 2010 Oct;77(10):650. doi: 10.3949/ccjm.77b.10010.

A DNA methylation study of the amyloid precursor protein gene in several brain regions from patients with familial Alzheimer disease

Brohede J, Rinde M, Winblad B, Graff C.

J Neurogenet. 2010 Dec;24(4):179-81. doi: 10.3109/01677063.2010.503978. Epub 2010 Oct 4.

Zebrafish as a tool in Alzheimer's disease research

Newman M, Verdile G, Martins RN, Lardelli M.

Biochim Biophys Acta. 2011 Mar;1812(3):346-52. doi: 10.1016/j.bbadis.2010.09.012. Epub 2010 Oct 12.

Assessment of potential measures in models of progression in Alzheimer disease

McLaughlin T, Buxton M, Mittendorf T, Redekop W, Mucha L, Darba J, Jonsson L, Lacey L, Leibman C.

Neurology. 2010 Oct 5;75(14):1256-62. doi: 10.1212/WNL.0b013e3181f6133d.

Health economics and health policy issues in Alzheimer's disease

Rapp T.

J Nutr Health Aging. 2010 Oct;14(8):630-2. doi: 10.1007/s12603-010-0308-2.

Alzheimer's disease: the strength of association of costs with different measures of disease severity

Mauskopf J, Racketa J, Sherrill E.

J Nutr Health Aging. 2010 Oct;14(8):655-63. doi: 10.1007/s12603-010-0312-6.

Savings from sub-groups?: Policy guidance and Alzheimer's disease treatments

McNamee P, Vanoli A, Hutchings D, McKeith I, Bond J.

J Nutr Health Aging. 2010 Oct;14(8):664-8. doi: 10.1007/s12603-010-0313-5.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias